70 research outputs found

    ํ˜ธ๋ชจํ† ํ”ผ ์ˆœํ™˜ A-๋ฌดํ•œ๋Œ€์ˆ˜, ์ž ์žฌํ•จ์ˆ˜์™€ ์ฝ”ํ˜ธ๋ชฐ๋กœ์ง€ ์ด๋ก 

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (๋ฐ•์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์ˆ˜๋ฆฌ๊ณผํ•™๋ถ€, 2013. 2. ์กฐ์ฒ ํ˜„.An A-infinity algebra has "associative up to homotopy" structure. For an A-infinity algebra AA, we give a definition of strong homotopy inner products(if exist) which is the homotopy notion of cyclic inner products due to Kontsevich. From strong homotopy inner products we get several invariants which we call "potentials". We study their homotopy natures, gauge invariances etc. Also we find an explicit correspondence between cohomology elements of AA and isomorphism classes of strong homotopy inner products on AA.Abstract 1. Introduction 2. Homotopy cyclic A-infinity algebra 2.1. A-infinity algebra 2.2. Homotopy equivalence of A-infinity algebras 2.3. A-infinity bimodules and inner products 3. Formal noncommutative geometry 3.1. Noncommutative function rings and vector fields 3.2. Noncommutative de Rham theory 3.3. Kontsevich-Soibelman's theorem 4. Review of cohomology theories on A-infinity algebras 4.1. Hochschild (co)homology for A-infinity algebras 4.2. (Negative) cyclic cohomology for A-infinity algebras 5. Potentials of homotopy cyclic A-infinity algebras and proof of Theorem A 5.1. Potentials 5.2. Theorem A 6. Proof of Theorem B 6.1. Correspondences between algebra and formal noncommutative geometry 6.2. Explicit relations 6.3. Construction of an automorphism 6.4. A connection to the Kontsevich-Soibelman's result 6.5. Gapped filtered cases 6.5.1. Filtered A-infinity algebras 6.5.2. Weakly filtered A-infinity bimodule homomorphisms 6.5.3. Formal manifolds 6.5.4. Darboux theorem 6.5.5. Corespondences 6.5.6. Theorem B in the filtered case 7. Proof of Theorem C Abstract(in Korean) Acknowledgement(in Korean)Docto

    (A) STUDY ON THE IMPLEMENTATION OF DUE DILIGENCE AND ITS EFFECT : FOCUSSING ON THE MARINE HULL INSURANCE

    Get PDF
    A Study on the Implementation of Due Diligence and Its effect - Focussing on the Marine Hull Insurance - Marine Insurance is for the underwriter to indemnify the assured, in manner and to the extent there by agreed, against marine losses, that is to say, the losses incident to marine adventure. In marine hull insurance, a loss or damage to the assured's insured-against can be divided into two categories. The one is the losses which always can be covered from underwriters regardless of assured's due diligence to his insured-against such as the losses proximately caused by perils of the seas and Act of God, and the other is the losses which can be covered only if his due diligence have been proved. Accordingly, there may be some cases in which underwriters refuse to pay claims to the assured in case of his want of due diligence and actually, a lot of cases which an assured could not have been covered, existed through the history of marine hull insurance claims. Marine enterprisers such as ship's owners, managers, charterers and carriers should not overlook this kind of resonable care in running their business, and if they fail to do so, they might be in trouble with legal liability, to say nothing of their financial hardness and difficulty in management. Statistically, looking back the past marine accident cases in korea, the most parts of the accident are man-made disasters caused by want of due diligence. So, this study will focuss on this kind of marine losses and insurance clauses and other relevant rules containing due diligence such as due diligence of the assured in inchmaree clause, ITC-Hulls, 1983, and due diligence of carrier in Hague-Visby Rule and so on. This study also shows what the disadvantages to marine enterprisers are, caused by want of due diligence and the advantages of doing due diligence are. In conclusion, this study contends that marine enterprisers should perform due diligence in doing their business for both financial stability and good management of their companies. s

    Unilateral Restless Legs Syndrome

    Get PDF
    ํ•˜์ง€๋ถˆ์•ˆ์ฆํ›„๊ตฐ์€ ํ•˜์ง€์— ์›€์ง์ด๊ณ  ์‹ถ์€ ์ถฉ๋™์ด ์žˆ๊ณ  ๋ถˆํŽธํ•˜๊ฑฐ๋‚˜ ๊ธฐ๋ถ„ ๋‚˜์œ ๋Š๋‚Œ์ด ๋™๋ฐ˜๋˜๋ฉฐ, ์ด๋Ÿฌํ•œ ์ถฉ๋™์ด๋‚˜ ๊ฐ๊ฐ ์ฆ์ƒ์ด ์‰ฌ๊ฑฐ๋‚˜ ์•‰๊ฑฐ๋‚˜ ๋ˆ•๋Š” ๊ฒƒ์ฒ˜๋Ÿผ ํ™œ๋™์ด ์ ์„ ๋•Œ ๋ฐœ์ƒํ•˜๊ฑฐ๋‚˜ ์•…ํ™”๋œ๋‹ค. ์ด๋Ÿฌํ•œ ์ฆ์ƒ์€ ์›€์ง์ด๋ฉด ๋ถ€๋ถ„์ ์œผ๋กœ ํ˜น์€ ์™„์ „ํ•˜๊ฒŒ ์‚ฌ๋ผ์ง€๋ฉฐ, ๋‚ฎ๋ณด๋‹ค๋Š” ๋ฐค์— ์•…ํ™”๋˜๊ฑฐ๋‚˜ ๋ฐค์—๋งŒ ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒƒ์„ ํŠน์ง•์ด๋‹ค. ํ•˜์ง€๋ถˆ์•ˆ์ฆํ›„๊ตฐ์˜ ์ฆ์ƒ์€ ๋Œ€๊ฐœ ์–‘์ธก ํ•˜์ง€์—์„œ ๋น„์Šทํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚˜์ง€๋งŒ ์ „์ฒด ํ™˜์ž์˜ 29%๋Š” ํ•œ์ชฝ์—์„œ ์ฆ์ƒ์ด ๋” ์‹ฌํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚œ๋‹ค. ํ•˜์ง€๋งŒ ์ง€๊ธˆ๊นŒ์ง€ ํŽธ์ธก ํ•˜์ง€์— ์ฆ์ƒ์ด ๊ตญํ•œ๋œ ๊ฒฝ์šฐ๋Š” ์„ธ ๊ฑด์˜ ์ฆ๋ก€๊ฐ€ ์žˆ์—ˆ๋‹ค.3 ์ €์ž๋“ค์€ ํ•˜์ง€๋ถˆ์•ˆ์ฆํ›„๊ตฐ์˜ ์ง„๋‹จ๊ธฐ์ค€์— ๋งž๊ณ , ์ด์ฐจ์  ์›์ธ์ด ์—†์œผ๋ฉฐ ํŽธ์ธก ์ƒํ•˜์ง€์— ๊ตญํ•œ๋œ ํŠน๋ฐœํ•˜์ง€๋ถˆ์•ˆ ์ฆํ›„๊ตฐ์˜ ์ฆ๋ก€๋ฅผ ๊ฒฝํ—˜ํ•˜์˜€๊ธฐ์— ๋ณด๊ณ ํ•œ๋‹ค.OAIID:oai:osos.snu.ac.kr:snu2012-01/102/2014017262/14SEQ:14PERF_CD:SNU2012-01EVAL_ITEM_CD:102USER_ID:2014017262ADJUST_YN:YEMP_ID:A079623DEPT_CD:801CITE_RATE:0DEPT_NM:์˜ํ•™๊ณผSCOPUS_YN:NCONFIRM:

    ์Šคํ‹ฐ๋ฆด ์—ผ๋ฃŒ์™€ ๋ณด๋””ํ”ผ ์Šคํ‹ฐ๋ฆด ์—ผ๋ฃŒ๋กœ ์ด๋ค„์ง„ ์ง‘์ค‘๋œ ๋ผ์ด๋ธŒ๋Ÿฌ๋ฆฌ๋ฅผ ํ†ตํ•œ ํ˜•๊ด‘ ํ”„๋กœ๋ธŒ์˜ ๊ฐœ๋ฐœ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (๋ฐ•์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์ž์—ฐ๊ณผํ•™๋Œ€ํ•™ ํ™”ํ•™๋ถ€, 2018. 2. ํ™์ข…์ธ.Fluorescent probes based on small molecules are versatile tools for optical imaging and analytical sensing owing to their high sensitivity levels, fast response times, and simplicity. In addition, the development of a new probe is as important as its usefulness. Although many researchers have developed numerous fluorescent molecular probes, systematic probe development approaches are still lacking. An early conventional strategy for probe development is the target-oriented approach. Probes have been designed based on available empirical knowledge of molecular recognition mechanisms for individual targets. However, this strategy has serious limitations when studying unknown targets. Meanwhile, diversity-oriented fluorescent probe libraries with broad chemical diversity can be an alternative means of discovering new probes for targets that may not be accessible with known sensing moieties. Nevertheless, this strategy has a very low success rate despite the great investments in labor and time. As an alternative to both strategies, we considered focused fluorescent probe libraries that were designed to aid in the development of fluorescent probes based on an understanding of the target or target family. Sensing moieties of our probes were focused on the target family. Herein, we demonstrate the effectiveness of a focused library consisting of sensing moieties and styryl-based fluorescent dyes to provide selective probes for the detection of various targets. First, we prepared a focused fluorescent probe library for metal cations that was developed by combining metal cation ligand moieties and picolinium/quinolinium moieties as combinatorial blocks, which were connected through a styryl group. Selective probes for Hg2+, Ag+, and Zn2+ can be found in this library. Secondly, we constructed a focused probe library for phosphorylated biomolecules using metal complexes obtained from the previous library having a high binding affinity levels for metal cations. From the metal complexes, a selective probe for dTTP was developed. Thirdly, several of our styryl dyes from the previous library showed enhanced fluorescence in cells, and we found fluorescent nucleic acid probes. The feasibility of these probes was confirmed by cellular nucleic acid digestion experiments. Fourth, we developed a ratiometric fluorescent hydrogen peroxide probe, 1A. This probe was used to quantify glucose in diluted urine with enzyme-assisted glucose oxidation. Furthermore, we demonstrated that probe 1A could detect the activities of various oxidases as well as the presence and quantity of specific biomolecules by means of enzyme-assisted metabolism. Lastly, we developed a fluorescent imaging probe based on styryl BODIPY, v-BDP, for a mitochondria-targeting cancer therapy study. This was developed to deliver anticancer drugs to the mitochondria through triggering with intracellular esterase.Part 1. General introduction 1 1.1 Fluorescence and fluorophore 2 1.2 Fluorescence modulation 12 1.3 Development of molecular fluorescent probe strategy 21 1.4 References 25 Part 2. Development of fluorescent probes based on picolinium/ quinolinium based styryl dye from focused libraries 27 2.1 Introduction to styryl dye 27 2.2 Fluorescent metal cation probes 31 2.2.1 Introduction 31 2.2.2 Data & results 33 2.2.3 Experimental section 39 2.2.4 References 59 2.3 Fluorescent thymidine triphosphate probe 61 2.3.1 Introduction 61 2.3.2 Data & results 62 2.3.3 Experimental section 68 2.3.4 References 69 2.4 Fluorescent nucleic acid probes 71 2.4.1 Introduction 71 2.4.2 Data & results 72 2.4.3 Experimental section 79 2.4.4 References 83 2.5 Ratiometric fluorescent hydrogen peroxide probes 87 2.5.1 Introduction 87 2.5.2 Data & results 88 2.5.3 Experimental section 96 2.5.4 References 102 Part 3. Development of fluorescent mitochondria targeting imaging probes based on styryl BODIPY 106 3.1.1 Introduction to BODIPY 106 3.1.2 Introduction to cancer cells 110 3.2 Synthesis and photophysical properties of mono styryl BODIPY dyes 117 3.2.1 Introduction 117 3.2.2 Data & results 118 3.2.3 Experimental section 125 3.2.4 References 138 3.3 Mitochondria targeting cellular imaging probe based on picolinium styryl BODIPY for cancer treatment study 139 3.3.1 Introduction 139 3.3.2 Data & results 140 3.3.3 Experimental section 145 3.3.4 References 146 ๊ตญ๋ฌธ ์ดˆ๋ก 148Docto

    Ship compartment modeling and naval architectural calculation based on a non-manifold polyhedron modeling kernel

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(๋ฐ•์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์กฐ์„ ํ•ด์–‘๊ณตํ•™๊ณผ,2006.Docto

    ๅ…ฌๅ…ฑ็›ฃๆŸป์˜ ็จ็ซ‹ๆ€ง์— ๋Œ€ํ•œ ็ก็ฉถ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ํ–‰์ •๋Œ€ํ•™์› :ํ–‰์ •ํ•™๊ณผ ์ •์ฑ…ํ•™์ „๊ณต,2003.Maste

    Synergistic anti-tumor effect of ionizing radiation and ฮฒ-lapachone on the human cancer cell line

    No full text
    ์˜ํ•™๊ณผ/๋ฐ•์‚ฌ[ํ•œ๊ธ€] ฮฒ-lapachone (ฮฒ-lap)์€ ๋‚จ์•„๋ฉ”๋ฆฌ์นด์— ์ž์ƒํ•˜๋Š” lapacho๋ž€ ๋‚˜๋ฌด์˜ ๊ป์งˆ์—์„œ ์ถ”์ถœํ•˜์—ฌ ํ•ฉ์„ฑ๋œ ๋ฌผ์งˆ๋กœ ๊ฐ์—ผ์งˆํ™˜์—์„œ ์•…์„ฑ์ข…์–‘๊นŒ์ง€ ํšจ๊ณผ๋ฅผ ๋‚˜ํƒ€๋‚ด๋Š” ๋‹ค์–‘ํ•œ ์•ฝ๋ฆฌ์ž‘์šฉ์„ ๊ฐ€์ง€๊ณ  ์žˆ๋‹ค. ํŠนํžˆ ฮฒ-lap์€ ๋ฐฑํ˜ˆ๋ณ‘, ๋‹ค๋ฐœ์„ฑ๊ณจ์ˆ˜์ข…, ์œ ๋ฐฉ์•”, ์ „๋ฆฝ์„ ์•” ๋“ฑ ๊ด‘๋ฒ”์œ„ํ•œ ์‚ฌ๋žŒ์•” ์„ธํฌ์ฃผ์— ๋Œ€ํ•ด์„œ ํ•ญ์•”์ž‘์šฉ์„ ๊ฐ€์ง€๋Š” ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ฮฒ-lap์€ ์ž์ฒด๋กœ๋„ ํ•ญ์•”ํšจ๊ณผ๋ฅผ ๋‚˜ํƒ€๋‚ด์ง€๋งŒ ๋ฐฉ์‚ฌ์„ ์ด๋‚˜ Taxol ๊ฐ™์€ ํ•ญ์•”์ œ์™€ ๋ณ‘์šฉํ•˜๋Š” ๊ฒฝ์šฐ, ํ•ญ์•”์ƒ์Šน์ž‘์šฉ์ด ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ฮฒ-lap ์ž์ฒด๋กœ๋Š” ๋…์„ฑ์„ ๋‚˜ํƒ€๋‚ด์ง€ ์•Š๋Š” ๋‚ฎ์€ ๋†๋„์—์„œ๋„ ๋ฐฉ์‚ฌ์„ ์„ ๋ณ‘์šฉํ•˜๋ฉด ๊ฐ•๋ ฅํ•œ ํ•ญ์•”์ž‘์šฉ์„ ๋‚˜ํƒ€๋‚ด๋Š” ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์ ธ ์žˆ์–ด, ๋ฐฉ์‚ฌ์„  ๋ฏผ๊ฐ์ œ๋กœ์จ ํ™œ์šฉ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์€ ์•ฝ๋ฌผ์ด๋‹ค. ๋ณธ ์—ฐ๊ตฌ์˜ ๋ชฉ์ ์€ ๋‹ค์Œ๊ณผ ๊ฐ™๋‹ค. 1. ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๋ฅผ in vitro, in vivo ์‹คํ—˜์„ ํ†ตํ•˜์—ฌ ๊ฒ€์ฆํ•˜๊ณ ์žํ•œ๋‹ค. 2.์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์— ์˜ํ•ด ์œ ๋„๋˜๋Š” NAD(P)H:quinone oxidoreductase (NQO1)์ด ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ์˜ ๊ธฐ์ „์ž„์„ ์ฆ๋ช…ํ•˜๊ณ ์ž ํ•œ๋‹ค. 3.์•”์„ธํฌ์—์„œ NQO1์˜ ๋ฐœํ˜„ ์ •๋„๋ฅผ ์•Œ์•„๋‚ด๋ฉด ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๋ฅผ ์˜ˆ์ธกํ•  ์ˆ˜ ์žˆ๋Š”์ง€ ์•Œ์•„๋ณด๊ณ ์ž ํ•œ๋‹ค. ์ด๋Ÿฐ ์—ฐ๊ตฌ๋ชฉ์ ์„ ๊ฒ€์ฆํ•˜๊ธฐ ์œ„ํ•œ ๊ฐ€์„ค๋กœ๋Š” โ€œ1. ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๋Š” ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์— ์˜ํ•ด ์œ ๋„๋˜๋Š” NQO1์— ์˜ํ•ด ฮฒ-lap ํ•ญ์•”ํšจ๊ณผ๊ฐ€ ์ฆ์ง„๋˜๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. 2. NQO1 ๋ฐœํ˜„ ์ •๋„๋ฅผ ์น˜๋ฃŒ ์ „ ํ™•์ธํ•˜๋ฉด ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๋ฅผ ์˜ˆ์ธกํ•  ์ˆ˜ ์žˆ๋‹คโ€๋กœ ์ •ํ•˜์˜€๋‹ค. ์‹คํ—˜์— ์‚ฌ์šฉ๋œ ์„ธํฌ์ฃผ๋กœ๋Š” ์‚ฌ๋žŒ ๋Œ€์žฅ์•”์—์„œ ๊ธฐ์›ํ•œ RKO ์„ธํฌ์ฃผ, ์‚ฌ๋žŒ ํ์•”์—์„œ ๊ธฐ์›ํ•œ A549 ์„ธํฌ์ฃผ, ์‚ฌ๋žŒ ๋‘๊ฒฝ๋ถ€์ข…์–‘์—์„œ ๊ธฐ์›ํ•œ AMC-HN-1, -3, -4, -6, -9์„ ์ด์šฉํ•˜์˜€๋‹ค. ์‹คํ—˜์— ์‚ฌ์šฉ๋œ ์•ฝ๋ฌผ๋กœ๋Š” ฮฒ-lap๊ณผ NQO1 ์–ต์ œ์ž์ธ dicumarol์„ ๊ตฌ์ž…ํ•˜์—ฌ ์‚ฌ์šฉํ•˜์˜€๋‹ค. ์„ธํฌ์ƒ์กด์œจ์€ ์„ธํฌ์ง‘๋ฝํ˜•์„ฑ๋Šฅ๋ฒ•๊ณผ MTT assay์„ ์ด์šฉํ•˜์˜€๊ณ , NQO1, p53, p21, NF-kB์˜ ๋ฐœํ˜„์€ western blot์„ ์ด์šฉํ•˜์—ฌ ํ™•์ธํ•˜์˜€๋‹ค. ฮฒ-lap๊ณผ ๋ฐฉ์‚ฌ์„ ์— ์˜ํ•ด ์œ ๋„๋˜๋Š” ์„ธํฌ์‚ฌ๋ฉธ์„ ๊ด€์ฐฐํ•˜๊ธฐ ์œ„ํ•ด์„œ DAPI ์—ผ์ƒ‰, DNA ๋ถ„์ ˆ ๊ด€์ฐฐ๋ฒ•, Annexin V-PI ์—ผ์ƒ‰๋ฒ•์„ ์ด์šฉํ•˜์˜€๊ณ , ์„ธํฌ์ฃผ๊ธฐ์˜ ๋ณ€ํ™”๋ฅผ ๊ด€์ฐฐํ•˜๊ธฐ ์œ„ํ•˜์—ฌ PI ์—ผ์ƒ‰ ํ›„ ์œ ์„ธํฌ ๋ถ„์„์„ ์‹œํ–‰ํ•˜์˜€๋‹ค. ๋ฐฉ์‚ฌ์„ ์กฐ์‚ฌ์— ์˜ํ•œ NQO1์˜ ๋ฐœํ˜„ ์ฆ๊ฐ€๋ฅผ ๊ด€์ฐฐํ•˜๊ธฐ ์œ„ํ•˜์—ฌ ๋ฉด์—ญํ˜•๊ด‘์—ผ์ƒ‰์„ ์‹œํ–‰ํ•˜์˜€๋‹ค. ์„ธํฌ์ง‘๋ฝํ˜•์„ฑ๋Šฅ๋ฒ•์œผ๋กœ ๋‹ค์–‘ํ•œ ์„ธํฌ์ฃผ์—์„œ NQO1 ๋ฐœํ˜„ ์ •๋„์™€ ฮฒ-lap์˜ ์„ธํฌ๋…์„ฑ์˜ ๊ด€๊ณ„๋ฅผ ์•Œ์•„ ๋ณด์•˜๋‹ค. ๋˜ํ•œ ฮฒ-lap๊ณผ ๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๊ฐ€ dicumarol์— ์˜ํ•ด ์†Œ๋ฉธ๋˜๋Š”์ง€๋ฅผ ํ™•์ธํ•˜์˜€๋‹ค. In vitro ์‹คํ—˜ ๊ฒฐ๊ณผ๋ฅผ ์ƒ์ฒด๋‚ด์—์„œ ํ™•์ธํ•˜๊ธฐ ์œ„ํ•˜์—ฌ ๋ˆ„๋“œ ๋งˆ์šฐ์Šค๋ฅผ ์ด์šฉํ•˜์—ฌ ์ข…์–‘์„ฑ์žฅ ์ง€์—ฐ์„ ๊ด€์ฐฐํ•˜์˜€๊ณ , ๋งˆ์šฐ์Šค์˜ ์ข…์–‘์—์„œ ์ฑ„์ทจํ•œ ์กฐ์ง์„ ๋ƒ‰๋™๋ณด๊ด€ ํ›„ TUNEL ์—ผ์ƒ‰์„ ์‹œํ–‰ํ•˜์—ฌ ์„ธํฌ์‚ฌ๋ฉธ์„ ๊ด€์ฐฐ ํ•˜์˜€๋‹ค. ์œ„์˜ ์‹คํ—˜๊ฒฐ๊ณผ๋ฅผ ์š”์•ฝํ•˜๋ฉด ๋‹ค์Œ๊ณผ ๊ฐ™๋‹ค. 1. 5 mM b-lap๊ณผ 6 Gy ์ด์˜จํ™”๋ฐฉ์‚ฌ์„  ๋‹จ๋… ์ฒ˜๋ฆฌ์‹œ ๊ฐ๊ฐ 67%, 42%์˜ ์„ธํฌ์‚ฌ๊ฐ€ ์žˆ์—ˆ์œผ๋‚˜ ๋ณ‘์šฉ์‹œ 89%์˜ ์„ธํฌ์‚ฌ๊ฐ€ ์žˆ์–ด, b-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„  ๊ฐ„์˜ ์ƒ์Šน์ž‘์šฉ์„ ๊ด€์ฐฐํ•  ์ˆ˜ ์žˆ์—ˆ๊ณ , ๋ฐฉ์‚ฌ์„ ์กฐ์‚ฌ ํ›„ 4์‹œ๊ฐ„ ํ›„์— b-lap์„ ํˆฌ์—ฌํ•˜์—ฌ๋„ ๋™์‹œ ํˆฌ์—ฌํ•œ ๊ฒฝ์šฐ์™€ ๋น„์Šทํ•œ ๊ฒฐ๊ณผ๋ฅผ ๋ณด์—ฌ, ๊ทธ ๊ธฐ์ „์€ b-lap์ด DNA ์†์ƒ๋ณต๊ตฌ๋ฅผ ์–ต์ œํ•˜๋Š” ๊ฒƒ์ด ์•„๋‹˜์„ ์•Œ์•˜๋‹ค. 2. b-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„  ๋ณ‘์šฉ ์‹œ ์ผ์ฐจ์ ์œผ๋กœ ์„ธํฌ์‚ฌ๋ฉธ์ด ์ผ์–ด๋‚˜๊ณ  8์‹œ๊ฐ„ ์ดํ›„์—๋Š” ์„ธํฌ๊ดด์‚ฌ๋„ ๋™์‹œ์— ์ผ์–ด๋‚ฌ๋‹ค. 3. ๋ฐฉ์‚ฌ์„ ์— ์˜ํ•ด ์œ ๋„๋˜๋Š” p53์ด๋‚˜ NF-kB๋Š” b-lap์— ์˜ํ•ด ์–ต์ œ๋˜๊ฑฐ๋‚˜ ํŒŒ๊ดด๋˜์—ˆ๋Š”๋ฐ, p53์˜ ๋ฐœํ˜„์€ ๋ฐฉ์‚ฌ์„  ๋‹จ๋…์ฒ˜๋ฆฌ ์‹œ ์ตœ๊ณ  2.8๋ฐฐ ์ฆ๊ฐ€ํ•˜์˜€์ง€๋งŒ, b-lap ๋‹จ๋…๊ตฐ์ด๋‚˜ ๋ณ‘์šฉ๊ตฐ์—์„œ๋Š” ์˜คํžˆ๋ ค 50% ๋‚ด์™ธ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. 4. ๋ฐฉ์‚ฌ์„ ์— ์˜ํ•ด ์ผ์–ด๋‚˜๋Š” G2๊ธฐ ์„ธํฌ์ฃผ๊ธฐ ์ •์ง€๊ฐ€ b-lap์— ์˜ํ•ด ์–ต์ œ๋˜์–ด ์„ธํฌ์‚ฌ๊ฐ€ ํ•ญ์ง„๋˜์—ˆ๋‹ค. 5. b-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๋Š” ๋ฐฉ์‚ฌ์„ ์— ์˜ํ•ด ์œ ๋„๋˜๋Š” NQO1์˜ ๋ฐœํ˜„์— ๊ธฐ์ธํ•˜๋ฉฐ, NQO1์„ dicumarol๋กœ ์–ต์ œํ•  ๊ฒฝ์šฐ ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๋Š” ์†Œ์‹ค๋˜์—ˆ๋‹ค. 6. b -lap์— ์˜ํ•œ ์„ธํฌ๋…์„ฑ์€ NQO1 ๋ฐœํ˜„ ์ •๋„์™€ ๋น„๋ก€ํ•˜๋Š” ์–‘์ƒ์„ ๋ณด์˜€๋Š”๋ฐ, NQO1 ๋ฐœํ˜„์ด ๋น„๊ต์  ๋†’์€ AMC-HN-6๊ณผ A549 ์„ธํฌ์ฃผ์—์„œ๋Š” ฮฒ-lap (5 mM) ์ฒ˜๋ฆฌ ์‹œ ๊ฐ๊ฐ 84%, 87% ์„ธํฌ์‚ฌ๊ฐ€ ๋ฐœ์ƒํ•˜์˜€๋‹ค. 7. In vitro ์‹คํ—˜์—์„œ ํ™•์ธํ•œ ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๋Š” ๋ˆ„๋“œ ๋งˆ์šฐ์Šค์˜ ์ข…์–‘์„ฑ์žฅ์ง€์—ฐ ์ด์šฉํ•œ in vivo ์‹คํ—˜์„ ํ†ตํ•ด์„œ๋„ ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ด์ƒ์˜ ๊ฒฐ๊ณผ๋ฅผ ์ข…ํ•ฉํ•˜์—ฌ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ๊ฒฐ๋ก ์„ ์–ป์„ ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ฒซ์งธ, ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”์ƒ์Šนํšจ๊ณผ๋Š” NQO1 ๋ฐœํ˜„ ์ •๋„์™€ ๋น„๋ก€ํ•˜๋ฉฐ, NQO1 ๋ฐœํ˜„ ์ •๋„๋กœ ฮฒ-lap๊ณผ ์ด์˜จํ™”๋ฐฉ์‚ฌ์„ ์˜ ํ•ญ์•”ํšจ๊ณผ๋ฅผ ์˜ˆ์ธกํ•˜๋Š” ๊ฒƒ์ด ๊ฐ€๋Šฅํ•  ๊ฒƒ์œผ๋กœ ์ƒ๊ฐ๋œ๋‹ค. ๋‘˜์งธ, ๋ฐฉ์‚ฌ์„ ์— ์ €ํ•ญ์„ฑ์„ ๊ฐ€์ง€๋Š” ์ข…์–‘๋„ ๋ฐฉ์‚ฌ์„ ์กฐ์‚ฌ๋กœ NQO1์ด ์œ ๋„ ๋ฐœํ˜„๋˜๋ฉด, b-lap๊ณผ ๋ณ‘์šฉํ•˜์—ฌ ํšจ๊ณผ์ ์ธ ์น˜๋ฃŒ๋ฅผ ํ•  ์ˆ˜ ์žˆ์„ ๊ฒƒ์ด๋‹ค. [์˜๋ฌธ] ฮฒ-lapachone (ฮฒ-lap), a natural o-naphthoquinone, presents in the bark of the lapacho tree, it is cytotoxic against a variety of human cancer, including colon, prostate, promyelocytic leukemia, breast, and lung and potentiates the anti-tumor effect of Taxol. In addition, ฮฒ-lap has been reported to radiosensitize cancer cells by inhibiting the repair of radiation-induced DNA damage with little toxicity ฮฒ-lap alone. At lower doses, it is a radiosensitizer of a number of human cancer cell lines. However, the mechanism of cell death triggered by ฮฒ-lap is unknown. Recently, new hypothesis suggested that ฮฒ-lap triggers apoptosis in a number of human cancer cell lines through a unique apoptotic pathway that is dependent upon NQO1, a two-electron reductase. In the present study, we investigated the cytotoxicity of ฮฒ-lap against human cells as well as the combined effect of ฮฒ-lap and ionizing radiation for in vitro and in vivo studies. An incubation of RKO cells with 5 ฮผM of ฮฒ-lap for 4 h killed almost 90% of the clonogenic cells. An incubation of RKO cells with 5 ฮผM of ฮฒ-lap for 4 h or longer also caused massive cell death including apoptosis and necrosis. Unlike other cytotoxic agents, ฮฒ-lap did not increase the expression of p53 and p21 and it suppressed the NF-ฮบB expression. Radiation and ฮฒ-lap acted synergistically in including clonogenic cell death and apoptosis in RKO cells when ฮฒ-lap treatment was applied after but not before the radiation exposure of the cells. Interestingly, a 4 h treatment with 5 ฮผM of ฮฒ-lap starting 2, 4, 8 h after irradiation was as effective as that stating immediately after irradiation. The mechanisms of ฮฒ-lap induced cell killing is controversial but a recent hypothesis is that ฮฒ-lap is activated by NAPD(P)H: quinone-oxidoreductase (NQO1) in the cells followed by an elevation of cytoslic Ca2+ level and activation of proteases leading to apoptosis. It has been reported that NQO1 level in cells is markedly up-regulated at 4 h after irradiation and for longer than 24 h after irradiation. Indeed, using immunological staining of NQO1, we observed a significant elevation of NQO1 expression in RKO cells 4 h after 2.5 Gy irradiation. Such a prolonged elevation of NQO1 level after irradiation may be the reasons why the ฮฒ-lap treatment applied 4 h after irradiation was as effective as that applied immediately after irradiation in killing the cells. In view of the fact that the repair of radiation-induced damage is usually completed within 1-2 h after irradiation, it is highly likely that the ฮฒ-lap treatment applied 4 h after irradiation could not inhibit the repair of radiation-induced damage. NQO1 expression directly correlated with sensitivity to a 4-h pulse of ฮฒ-lap in various cancer cell lines, and the NQO1 inhibitor, dicoumarol, significantly protected NQO1-expressing cells from all aspects of ฮฒ-lap toxicity. NQO1 levels significantly correlated with ฮฒ-lap sensitivity. Cell cycle analysis was performed on ฮฒ-lap-treated cells using PI staining and flow cytometry. Although the result showed no apparent change in the cell cycle after ฮฒ-lap treatment, the appearance of apoptotic cells (<2 N) was accompanied by the disappearance of G0/G1 cells. The increase of p21 by ฮฒ-lap was not found in RKO human colon cancer cell lines. However, ฮฒ-lap inhibited G2 check point by irradiation. For in vivo study, RKO cells were injected S.C. into the hind-leg of Nu/Nu mice, and allowed to grow to 130 mm2 tumor. The mice were i.p. injected with ฮฒ-lap or saline 2 h after irradiation of tumors with 10 Gy of X-ray. The radiation induced growth delay was increased by 2.4 ฮผg/g of ฮฒ-lapachone. Taken together, we may conclude that the synergistic interaction of radiation and ฮฒ-Lap in killing cancer cells is not due to radiosensitization by ฮฒ-lap but to enhancement of ฮฒ-lap cytotoxocity by radiation through up-regulation of NQO1. The fact that NQO1 is elevated in tumors and that radiation causes prolonged increase of the NQO1 expression may be exploited to preferentially kill tumor cells using ฮฒ-lap in combination with radiotherapy. We expect that ฮฒ-lap could work effectively as a radiosensitizer, even against the most radioresistant human cancer cell lines. Future studies on the nature of damage caused by NQO1-directed antitumor agents will be necessary to fully understand the complex relationship between NQO1 levels and ultimate toxicity. In summary, our results provide evidence that NQO1 is responsible for bioactivation of antitumor quinones in human tumor cells.ope

    Efficacy and tolerability of tolterodine in children with neurogenic bladder

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์˜ํ•™๊ณผ ๋น„๋‡จ๊ธฐ๊ณผํ•™์ „๊ณต,2005.Maste

    Gene-centered Methodology and Molecular Biology

    No full text
    This paper investigates the role and the significance of genecentered methodology in molecular biology. I claim that methodological considerations has played an important role in the historical development of molecular biology and are likely to do the same in future molecular biology research. I also claim that there are certain limitations with regard to the usefulness of the genecentered methodology in molecular biology research. I discuss the views of Lewontin, Keller and Morange on this issue to argue my claims
    • โ€ฆ
    corecore